Structural analysis of the GAP-related domain from neurofibromin and its implications

EMBO Journal

Volumn 17, Issue 15, 1998, Pages 4313-4327

  Scheffzek, Klaus ^c   Ahmadian, Mohammad Reza ^c   Wiesmüller, Lisa ^a   Kabsch, Wolfgang ^b   Stege, Patricia ^c   Schmitz, Frank ^c   Wittinghofer, Alfred ^c  

^a UNIVERSITY OF HAMBURG   (Germany)

^b MAX PLANCK INSTITUTE FOR MEDICAL RESEARCH   (Germany)

^c MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

Cancer; GTP hydrolysis; Neurofibromatosis; NF1; Ras

Indexed keywords

GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; NEUROFIBROMIN; RAS PROTEIN;

ARTICLE; HUMAN; MISSENSE MUTATION; NEUROFIBROMATOSIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN SECONDARY STRUCTURE; PROTEIN STRUCTURE; SEQUENCE HOMOLOGY; X RAY CRYSTALLOGRAPHY;

ALTERNATIVE SPLICING; AMINO ACID SEQUENCE; CATALYSIS; CRYSTALLOGRAPHY, X-RAY; GTP PHOSPHOHYDROLASES; GTPASE-ACTIVATING PROTEINS; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTATION; NERVE TISSUE PROTEINS; NEUROFIBROMIN 1; PROTEIN BINDING; PROTEIN STRUCTURE, SECONDARY; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RAS GTPASE-ACTIVATING PROTEINS; RAS PROTEINS; STRUCTURE-ACTIVITY RELATIONSHIP; TUBULIN;

EID: 0032479992     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/17.15.4313     Document Type: Article

References (84)

1. GAP and Neurofibromin. J. Biol. Chem., 271, 16409-16415.
2. Ahmadian, M.R., Hoffmann, U., Goody, R.S. and Wittinghofer, A. (1997a) Individual rate constants for the interaction of Ras proteins with GTPase-activating proteins determined by fluorescence spectroscopy. Biochemistry, 36, 4535-4541.
3. Ahmadian, M.R., Stege, P., Scheffzek, K. and Wittinghofer, A. (1997b) Confirmation of the arginine-finger hypothesis tor the GAP-stimulated GTP-hydrolysis reaction of Ras. Nature Struct. Biol., 4, 686-689.
4. Andersen, L.B., Ballester, R., Marchuk, D.A., Chang, E., Gutman, D.H., Saulino, A.M., Camonis, J., Wigler, M. and Collins, F.S. (1993) A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activating protein activity. Mol. Cell. Biol., 13, 487-495.
5. Bader, J.L. (1986) Neurofibromatosis and cancer. Ann. NY Acad. Sci., 486, 57-65.
6. Ballester, R., Marchuk, D., Boguski, M., Saulino, A., Letcher, R., Wigler, M. and Collins, F. (1990) The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell, 63, 851-859.
7. Basu, T.N., Gutmann, D.H., Fletcher, J.A., Glover, T.W., Collins, F.S. and Downward, J. (1992) Aberrant regulation of ras proteins in malignant cells from type 1 neurofibromatosis patients. Nature, 356, 713-715.
8. Bollag, G. and McCormick, F. (1991) Differential regulation of rasGAP and neurofibromatosis gene product activities. Nature, 351, 576-579.
9. Bollag, G., McCormick, F. and Clark, R. (1993) Characterization of full-length neurofibromin: tubulin inhibits ras GAP activity. EMBO J., 12, 1923-1927.
10. Brannan, C.I. et al. (1994) Targeted disruption of the neurofibromatosis type-1 gene leads to developmental abnormalities in heart and various neural crest-derived tissues. Genes Dev., 8, 1019-1029.
11. ras measured by a novel fluorescence anisotropy method. J. Biol. Chem., 268, 10914-10919.
12. Bruenger, A.T. (1991) X-PLOR, a system for crystallography and NMR Yale University, New Haven, CT.
13. Cawthon, R.M. et al. (1990) A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure and point mutations. Cell, 62, 193-201.
14. Chabre, M. (1990) Aluminofluoride and beryllofluoride complexes: new phosphate analogs in enzymology. Trends Biochem. Sci., 15, 6-10.
15. DeClue, J.E., Cohen, B.D. and Lowy, D.R. (1991) Identification and characterization of the neurofibromatosis type 1 protein product. Proc. Natl Acad. Sci. USA, 88, 9914-9918.
16. ras contributes to malignant tumour growth in von Recklinghausen (type 1) neurofibromatosis. Cell, 69, 265-273.
17. Eccleston, J.F., Moore, K.J.M., Morgan, L., Skinner, R.H. and Lowe, P.N. (1993) Kinetics of interaction between normal and proline 12 Ras and the GTPase-activating proteins, P120-GAP and neurofibromin. J. Biol. Chem., 268, 27012-27019.
18. Fridman, M. et al. (1994) The minimal fragments of c-Rat-1 and NF1 that can suppress v-Ha-Ras-induced malignant phenotype. J. Biol. Chem., 269, 30105-30108.
19. Gaul, U., Mardon, G. and Rubin, G.M. (1992) A putative ras GTPase activating protein acts as a negative regulator of signalling by the Sevenless receptor tyrosine kinase. Cell, 68, 1007-1019.
20. H-ras complexed with the effector protein Raf-RBD and the GTPase activating protein GAP. Biochemistry, 35, 10308-10320.
21. Gideon, P., John, J., Frech, M., Lautwein, A., Clark, R., Scheffler, J.E. and Wittinghofer, A. (1992) Mutational and kinetic analysis of the GTPase-activating protein (GAP)-P21 interaction: The C-terminal domain of GAP is not sufficient for full activity. Mol. Cell. Biol., 12, 2050-2056.
22. Golubic, M., Tanaka, K., Dobrowolski, S., Wood, D., Tsai, M.H., Marshall, M., Tamanoi, F. and Stacey, D.W. (1991) The GTPase stimulatory activities of the neurofibromatosis gene type 1 and the yeast IRA2 proteins are inhibited by arachidonic acid. EMBO J., 10, 2897-2903.
23. Gregory, P.E., Gutmann, D.H., Mitchell, A., Park, S., Boguski, M., Jacks, T., Wood, D.L., Jove, R. and Collins, F.S. (1993) Neurofibromatosis type 1 gene product (Neurofibromin) associates with microtubules. Somat. Cell Mol. Genet., 19, 265-274.
24. Griesser, J., Kaufmann, D., Eisenbarth, I., Bäuerle, C. and Krone, W. (1995) Ras-GTP regulation is not altered in cultured melanocytes with reduced levels of neurofibromin derived from patients with neurofibromatosis 1 (NF1). Biol. Chem. Hoppe-Seyler, 376, 91-101.
25. Guha, A., Lau, N., Huvar, I., Gutmann, D., Provias, J., Pawson, T. and Boss, G. (1996) Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene, 12, 507-513.
26. Gutmann, D.H. and Collins, F.S. (1993) The neurofibromatosis type 1 gene and its protein product. Neurofibromin. Neuron, 10, 335-343.
27. Gutmann, D.H., Boguski, M., Marchuk, D., Wigler, M., Collins, F.S and Ballester, R. (1993) Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis. Oncogene, 8, 761-769.
28. Gutmann, D.H., Geist, R.T., Rose, K. and Wright, D.E. (1995) Expression of two new protein isoforms of the neurofibromatosis type 1 gene product, neurofibromin, in muscle tissues. Dev. Dyn., 202, 302-311.
29. Henkemeyer, M., Rossi, D.J., Holmyard, D.P. Puri, M.C., Mbamalu, G., Harpal, K., Shih, T.S., Jacks, T. and Pawson, T. (1995) Vascular system defects and neuronal apoptosis in mice lacking Ras GTPase-activating protein. Nature, 377, 695-701.
30. Jacks, T., Shi, T.S., Schmitt, E.M., Bronson, R.T., Bernards, A. and Weinberg, R. (1994) Tumour predisposition in mice heterozygous for a targeted mutation in Nf1. Nature Genet., 7, 353-361.
31. Johnson, M.R., DeClue, J.E., Felzmann, S., Vass, W.C., Xu, G., White, R. and Lowy, D.R. (1994) Neurofibromin can inhibit ras-dependent growth by a mechanism independent of its GTPase-accelerating function. Mol. Cell. Biol., 14, 641-645.
32. Jones, T.A., Zou, J.Y., Cowan, S.W. and Kjelgaard, M. (1991) Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr., A47, 110-119.
33. Kabsch, W. (1993) Automatic processing of rotation diffraction data from crystal of initially unknown symmetry and cell constants. J. Appl. Crystallogr., 26, 795-800.
34. Kabsch, W. and Sander, C. (1983) Dictionary of protein secondary structures: pattern recognition of hydrogen-bonded and geometrical features. Biopolymers, 22, 2577-2637.
35. Klose, A.J. et al. (1998) Selective disactivation of neurotibromin GAP-activity in neurofibromatosis type 1 (NF1). Hum. Mol. Genet., 7, 1261-1268.
36. Kraulis, P. (1991) Molscript: a program to produce both detailed and schematic protein structures. J. Appl. Crystallogr., 24, 946-950.
37. Li, Y. et al. (1992) Somatic mutations in the neurofibromatosis 1 gene in human tumors. Cell, 69, 275-281.
38. Loewe, J. and Amos, L.A. (1998) Crystal structure of the bacterial cell-division protein FtsZ. Nature, 391, 203-206.
39. Lowy, D.R. and Willumsen, B.M. (1993) Function and regulation of Ras. Annu. Rev. Biochem., 62, 851-891.
40. Marchuk, D.A. et al. (1991) cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics, 11, 931-940.
41. Marshall, M.S., Hill, W.S., Ng, A.S., Vogel, U.S., Schaber, M.D., Scolnick, E.M., Dixon, R.A.F., Sigal, I. and Gibbs, J.B. (1989) A C-terminal domain of GAP is sufficient to stimulate ras p21 GTPase activity. EMBO J., 8, 1105-1110.
42. Martin, G.A. et al. (1990) The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell, 63, 843-849.
43. Merrit, E.A. and Bacon, D.J. (1997) Raster3D: Photorealistic molecular graphics. Methods Enzymol., 277, 505-524.
44. Milburn, M.V., Tong, L., DeVos, A.M., Brünger, A., Yamaizumi, Z., Nishimura, S. and Kim, S.-H. (1990) Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science, 247, 939-945.
45. Mittal, R., Ahmadian, M.R., Goody, R.S. and Wittinghofer, A. (1996) Formation of a transition state analog of the Ras GTPase reaction by Ras•GDP, tetrafluoroaluminate and GTPase-activating proteins. Science, 273, 115-117.
46. Morcos, P., Thapar, N., Tusneem, N., Stacey, D. and Tamanoi, F. (1996) Identification of neurofibromin mutants that exhibit allele specificity or increased Ras affinity resulting in suppression of activated ras alleles. Mol. Cell. Biol., 16, 2496-2503.
47. Mori, S., Satoh, T., Koide, H., Nakafuku, M., Villafranca, E. and Kaziro, Y. (1995) Inhibition of Ras/Raf interaction by anti-oncogenic mutants of neurofibromin, the neurofibromatosis type 1 (NFl) gene product, in cell-free systems. J. Biol. Chem., 270, 28834-28838.
48. Nakafuku, M., Nagamine, M., Ohtoshi, A., Tanaka, K., Toh-E, A. and Kaziro, Y. (1993) Suppression of oncogenic Ras by mutant neurofibromatosis type 1 genes with single amino acid substitutions. Proc. Natl Acad. Sci. USA, 90, 6706-6710.
49. Nishi, T., Lee, P.S.Y. Oka, K., Levin, V.A., Tanase, S., Morino, Y. and Saya, H. (1991) Differential expression of two types of the neurofibromatosis type 1 (NF1) gene transcripts related to neuronal differentiation. Oncogene, 6, 1555-1559.
50. ras with the GTPase-activating proteins p120-GAP and neurofibromin. Biochemistry, 34, 15592-15598.
51. Nogales, E., Wolf, S.G. and Downing, K.H. (1998) Structure of the αβ tubulin dimer by electron crystallography. Nature, 391, 199-203.
52. Nur-E-Kamal, M.S.A., Varga, M. and Maruta, H. (1993) The GTPase-activating NF1 fragment of 91 amino acids reverses v-Ha-Ras-induced malignant phenotype. J. Biol. Chem., 268, 22331-22337.
53. Pai, E.F., Krengel, U., Petsko, G.A., Goody, R.S., Kabsch, W. and Wittinghofer, A. (1990) Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 Å resolution: implications for the mechanism of GTP hydrolysis. EMBO J., 9, 2351-2359.
54. Ponder, B.A.J. (1990) Inherited predisposition to cancer. Trends Genet., 6, 213-218.
55. Val-19-activated phenotypes. Mol. Cell. Biol., 14, 815-821.
56. Purandare, S.M., Lanyon, W.G. and Connor, J.M. (1994) Characterisation of inherited and sporadic mutations in neurofibromatosis type-1. Hum. Mol. Genet., 3, 1109-1115.
57. Rey, I., Taylor-Harris, P., van Erp, H. and Hall, A. (1994) R-ras interacts with rasGAP, neurofibromin and c-raf but does not regulate cell growth or differentiation. Oncogene, 9, 685-692.
58. Riccardi, V.M. (1981) Von Recklinghausen neurofibromatosis. N. Engl. J. Med., 305, 1617-1627.
59. Riccardi, V.M. (1991) Neurofibromatosis: past, present and future. N. Engl. J. Med., 324, 1283-1285.
60. Riccardi, V.M. and Eichner, J.E. (1986) Neurofibromatosis: Phenotype, Natural History and Pathogenesis. Johns Hopkins University Press, Baltimore, MD, USA.
61. Scheffzek, K., Lautwein, A., Kabsch, W., Ahmadian, M.R. and Wittinghofer, A. (1996) Crystal structure of the GTPase-activating domain of human p120GAP and implications for the interaction with Ras. Nature, 384, 591-596.
62. Scheffzek, K., Ahmadian, M.R., Kabsch, W., Wiesmüller, L., Lautwein, A., Schmitz, F. and Wittinghofer, A. (1997) The Ras-RasGAP complex: Structural basis for GTPase activation and its loss in oncogenic Ras mutants. Science, 277, 333-338.
63. Serra, E., Puig, S., Otero, D., Gaona, A., Kruyer, H., Ars, E., Estivill, X. and Lázaro, C. (1997) Confirmation of a double-hit model for the NF1 gene in benign neurofibromas. Am. J. Hum. Genet., 61, 512-519.
64. Serth, J., Lautwein, A., Frech, M., Wittinghofer, A. and Pingoud, A. (1991) The inhibition of the GTPase activating protein-Ha-ras interaction by acidic lipids is due to physical association of the C-terminal domain of the GTPase activating protein with micellar structures. EMBO J., 10, 1325-1330.
65. Shen, M.H., Harper, P.S. and Upadhyaya, M. (1996) Molecular genetics of neurofibromatosis type 1 (NF1). J. Med. Genet., 33, 2-17.
66. Skinner, R.H., Picardo, M., Gane, N.M., Cook, N.D., Morgan, L., Rowedder, J. and Lowe, P.N. (1994) Direct measurement of the binding of RAS to neurofibromin using a scintillation proximity assay. Anal. Biochem., 223, 259-265.
67. Stanbridge, E.J. (1990) Human tumor suppressor genes. Annu. Rev. Genet., 24, 615-657.
68. Suzuki, Y., Suzuki, H., Kayama, T., Yoshimoto, T. and Shibahara, S. (1991) Brain tumors predominantly express the neurofibromatosis type 1 gene transcripts containing the 63 base insert in the region coding for GTPase activating protein-related domain. Biochem. Biophys. Res. Commun., 181, 955-961.
69. Tanaka, K., Nakafuku, M., Satoh, T. Marshall, M.S., Gibbs, J.B., Matsumoto, K., Kaziro, Y. and Toh-e, A. (1990a) S.cerevisiae genes IRA1 and IRA2 encode proteins that may be functionally equivalent to mammalian ras GTPase activating protein. Cell, 60, 803-807.
70. Tanaka, K., Nakafuku, M., Tamanoi, F., Kaziro, Y., Matsumoto, K. and Tohe, A. (1990b) IRA2, a second gene of Saccharomyces cerevisiae that encodes a protein with a domain homologous to mammalian ras GTPase-activating protein. Mol. Cell. Biol., 10, 4303-4313.
71. Tanaka, K., Lin, B.K., Wood, D.R. and Tamanoi, F. (1991) IRA2, an upstream negative regulator of RAS in yeast, is a RAS GTPase-activating protein. Proc. Natl Acad. Sci. USA, 88, 468-472.
72. The, I., Hannigan, G.E., Cowley, G.S., Reginald, S., Zhong, Y. Gusella, J.F., Hanharan, I.K. and Bernards, A. (1997) Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science, 276, 791-794.
73. Trahey, M. and McCormick, F. (1987) A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science, 238, 542-545.
74. Tsai, M.-H., Roudebush, M., Dobrowolski, S., Yu, C.-L., Gibbs, J.B. and Stacey, D.W. (1991) Ras GTPase-activating protein physically associates with mitogenically active phospholipids. Mol. Cell. Biol., 11, 2785-2793.
75. Upadhyaya, M., Osborn, M.J., Maynard, J., Kim, M.R., Tamanoi, F. and Cooper, D.N. (1997) Mutational and functional analysis of the neurofibromatosis type 1 (NF1) gene. Hum. Genet., 99, 88-92.
76. Viskochil, D. et al (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell, 62, 187-192.
77. Wallace, M.R. et al. (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science, 249, 181-186.
78. Wiesmüller, L. and Wittinghofer, A. (1992) Expression of the GTPase activating domain of the neurofibromatosis type 1 (NF1) gene in E.coli and role of the conserved lysine residue. J. Biol. Chem., 267, 10207-10210.
79. Wittinghofer, A. (1997) Signaling mechanistics: Aluminum fluoride for molecule of the year. Curr. Biol., 7, R682-R685.
80. Wolber, V., Maeda, K., Schumann, R., Brandmeier, B., Wiesmüller, L. and Wittinghofer, A. (1992) A universal expression-purification system based on the coiled-coil interaction of myosin heavy chain. Biotechnology, 10, 900-904.
81. Wood, D.R., Poullet, P., Wilson, B.A., Khalil, M., Tanaka, K., Cannon, J.F. and Tamanoi, F. (1994) Biochemical characterization of yeast RAS2 mutants reveals a new region of ras protein involved in the interaction with GTPase-activating proteins. J. Biol. Chem., 269, 5322-5327.
82. Xu, G. et al. (1990a) The neurofibromatosis type 1 gene encodes a protein related to GAP. Cell, 62, 599-608.
83. Xu, G.F., Lin, B., Tanaka, K., Dunn, D., Wod, D., Gesteland, R., White, R., Weiss, R. and Tamanoi, F. (1990b) The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GTPase and complements ira mutants of S.cerevisiae. Cell, 63, 835-841.
84. Xu, H. and Gutmann, D.H. (1997) Mutations in the GAP-related domain impair the ability of neurofibromin to associate with microtubules. Brain Res., 759, 149-152.